Seeking men and women over the age of 70 whose pancreatic cancer has spread to other parts of their body for a study comparing two different drug combination therapies.
We are comparing two different drug combinations that have already been approved by the FDA for pancreatic cancer to evaluate which is best for people over the age of 70. Participants will be randomly assigned to receive one or the other treatment.
What we're hoping for
We hope to identify which drug combination therapy works best to prolong the life of people over the age of 70 whose pancreatic cancer has spread to other parts of their body.
ClinicalTrials.gov Identifier: NCT04233866